Clinical Trial Update: Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating carfilzomib-based chemotherapy mobilization for autologous stem cell transplants in multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Kyprolis (carfilzomib)

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Multiple Myeloma | Phase 1 | Status: RECRUITING